Where Anti-ACE2 autoantibodies is reported
Also listed as: Angiotensin-converting enzyme 2
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| PACVS | ↑ elevated | healthy controls | Ecchymosis, skin edema, rash | Mantovani et al. 2024 |
Frequently asked questions
In which conditions is Anti-ACE2 autoantibodies altered?
In the OSMF atlas Anti-ACE2 autoantibodies is reported in PACVS. It is elevated in 1 across 1 entries.
Is there a standard clinical test for Anti-ACE2 autoantibodies?
The atlas entries for Anti-ACE2 autoantibodies do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Anti-ACE2 autoantibodies result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-30 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.